Document ID: chunk:federal_register_of_legislation:F2024L01065:clause:1_15
Version: federal_register_of_legislation:F2024L01065
Segment Type: clause
Provision Reference: sch 1 cl 15
Character Range: 9119–9655

15  Schedule 1 (table)
After:
Entecavir  Tablet 0.5 mg (as monohydrate)  Oral  Entecavir Viatris  after 30 September 2024—4 months stock by reference to usual demand of both Entecavir Viatris and Entecavir Mylan added together

insert:
Entecavir  Tablet 0.5 mg (as monohydrate)  Oral  ENTECLUDE  between 1 September 2024 and 31 October 2024—0 months stock by reference to usual demand
Entecavir  Tablet 1 mg (as monohydrate)    Oral  ENTECLUDE  between 1 September 2024 and 31 October 2024—0 months stock by reference to usual demand